CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
0 hedge funds and large institutions have $0 invested in Loncar China BioPharma ETF in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Jane Street
New York
|
-$276K |
| 2 |
GS
GTS Securities
New York
|
-$267K |
| 3 |
BBPWM
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
|
-$4.39K |
| 4 |
Morgan Stanley
New York
|
-$2.68K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| – | -$276K | -19,335 | Closed |
|
|
GS
2
GTS Securities
New York
| – | -$267K | -18,727 | Closed |
|
|
BBPWM
3
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| – | -$4.39K | -308 | Closed |
|
|
4
Morgan Stanley
New York
| – | -$2.68K | -188 | Closed |
|